The Recall Desk
CriticalFDA (Drugs)·D-0228-2017·Announced 2016-12-28

Sermorelin/GHRP-6 Injection Recalled for Non-Sterility and Microbial Contamination

Town and Country Compounding and Consultation Services is recalling Sermorelin/GHRP-6 Injection due to non-sterility and Bacillus circulans contamination.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 per the rubric.

Plain-English summary

Town and Country Compounding and Consultation Services is recalling 12 vials of Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial. The recall is due to non-sterility, with microbial contamination identified as Bacillus circulans.

The affected product is identified by lot #07172016@1 with an expiration date of 1/13/2017. The product was distributed in Massachusetts, New York, New Jersey, Florida, and Canada.

Consumers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
Manufacturer
Town and Country Compounding and Consultation Services
Category
Drug — Compounded Injectable
Hazard
Affected units
12

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • lot #07172016@1
  • exp 1/13/2017

Distribution

Distributed in 4 states:

Related recalls

Same hazard · microbial contamination

See all →